已收盤 06-18 16:00:00 美东时间
-0.080
-0.32%
This Agreement resolves the patent litigation UroGen initiated in response to Teva's submission of an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration ("FDA") seeking approval to market a
06-02 20:02
Janus Henderson launches two new ETFs targeting equity-driven income with downside protection and diversification beyond bonds.
05-01 03:13